These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New CD56 positive and cytotoxic T-cell cutaneous lymphomas from the World Health Organisation. Slater DN Br J Dermatol; 2003 Mar; 148(3):385-7. PubMed ID: 12653728 [No Abstract] [Full Text] [Related]
6. Erythrodermic cutaneous T-cell lymphoma with CD8+CD56+ leukaemic T cells in a young woman. Ohshima A; Tokura Y; Misawa J; Yagi H; Takigawa M Br J Dermatol; 2003 Oct; 149(4):891-3. PubMed ID: 14616391 [No Abstract] [Full Text] [Related]
7. Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation. Berger TG; Voll RE; Simon M; Kiesewetter F Acta Derm Venereol; 2004; 84(1):53-6. PubMed ID: 15040479 [TBL] [Abstract][Full Text] [Related]
8. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057 [TBL] [Abstract][Full Text] [Related]
9. A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Petrella T; Teitell MA; Spiekermann C; Meijer CJ; Franck F; Enache I Br J Dermatol; 2004 Jan; 150(1):174-6. PubMed ID: 14746651 [No Abstract] [Full Text] [Related]
10. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK. Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cells in human peripheral blood and primary cutaneous natural killer cell lymphomas may express cutaneous lymphocyte antigen. Chang SE; Kim MJ; Lee WS; Kang YK; Moon KC; Koh JK; Choi JH Acta Derm Venereol; 2003; 83(3):162-6. PubMed ID: 12816147 [TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous extranodal natural killer/T-cell lymphoma presenting as bilateral erythematous patches on the arms. Moon IJ; Kang HJ; Lee MW; Lee WJ Indian J Dermatol Venereol Leprol; 2017; 83(4):453-456. PubMed ID: 28474639 [TBL] [Abstract][Full Text] [Related]
13. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. Lucas M; Gadola S; Meier U; Young NT; Harcourt G; Karadimitris A; Coumi N; Brown D; Dusheiko G; Cerundolo V; Klenerman P J Virol; 2003 Feb; 77(3):2251-7. PubMed ID: 12525661 [TBL] [Abstract][Full Text] [Related]
14. The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset. Chieregato K; Zanon C; Castegnaro S; Bernardi M; Amati E; Sella S; Rodeghiero F; Astori G Blood Transfus; 2017 Jan; 15(1):93-100. PubMed ID: 27136441 [TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Linn YC; Hui KM Leuk Lymphoma; 2003 Sep; 44(9):1457-62. PubMed ID: 14565644 [TBL] [Abstract][Full Text] [Related]
16. Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Musha N; Yoshida Y; Sugahara S; Yamagiwa S; Koya T; Watanabe H; Hatakeyama K; Abo T Clin Exp Immunol; 1998 Aug; 113(2):220-8. PubMed ID: 9717971 [TBL] [Abstract][Full Text] [Related]
18. Pathologic quiz case: a 61-year-old man with a papular rash in a capelike distribution. Agranular CD4+CD56+ hematodermic neoplasm (blastic natural killer cell lymphoma). Lum SJ; Jain K; Honda S Arch Pathol Lab Med; 2005 Feb; 129(2):e47-8. PubMed ID: 15679448 [No Abstract] [Full Text] [Related]
19. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. Assaf C; Gellrich S; Whittaker S; Robson A; Cerroni L; Massone C; Kerl H; Rose C; Chott A; Chimenti S; Hallermann C; Petrella T; Wechsler J; Bagot M; Hummel M; Bullani-Kerl K; Bekkenk MW; Kempf W; Meijer CJ; Willemze R; Sterry W J Clin Pathol; 2007 Sep; 60(9):981-9. PubMed ID: 17018683 [TBL] [Abstract][Full Text] [Related]
20. Myeloid markers should be undertaken in cases of CD56 positivity to exclude granulocytic sarcoma. Kurata H; Okukubo M; Fukuda E; Ichihashi M; Ueda M Br J Dermatol; 2002 Sep; 147(3):609-11. PubMed ID: 12207615 [No Abstract] [Full Text] [Related] [Next] [New Search]